Lupishot 500mg/500mg Injection
Marketer
Lupin Ltd
Salt Composition
Imipenem (500mg) + Cilastatin (500mg)
Overview Lupishot 500mg/500mg Injection
Combiflex 500 mg/500 mg Injection, a dual-antibiotic formulation, combats severe bacterial infections. Administered only by a healthcare provider, this medication requires adherence to the prescribed schedule; complete the entire course regardless of symptom improvement. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin reactions (rashes), and localized injection site inflammation (redness, swelling, pain), typically resolving spontaneously. Severe side effects or allergic reactions (e.g., hives, itching, swelling, respiratory distress) necessitate immediate medical attention. Inform your physician of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential additive drowsiness. While generally not impairing driving ability, refrain from operating vehicles if experiencing somnolence or dizziness.
Uses of Lupishot 500mg/500mg Injection
Life-threatening bacterial infections
Major Benefits of Lupishot 500mg/500mg Injection:
Administering this medication requires a healthcare professional; patient self-administration is strictly prohibited.
Common Side effects of Lupishot 500mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
How to use Lupishot 500mg/500mg Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
How Lupishot 500mg/500mg Injection works:
The injectable formulation Lupishot, containing 500mg of each Imipenem and Cilastatin, utilizes a dual-drug approach. Imipenem, a potent antibiotic, disrupts bacterial cell wall synthesis, a crucial process for bacterial survival. Cilastatin, a dehydropeptidase I inhibitor, safeguards Imipenem from premature enzymatic degradation (by dehydropeptidase I). This protective action extends Imipenem's therapeutic effectiveness within the body.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Lupishot 500 mg/500 mg Injection lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Lupishot 500 mg/500 mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Lupishot 500 mg/500 mg Injection while breastfeeding appears to pose minimal risk. Available human data indicate negligible danger to the infant.
DrivingUNSAFE
Administering Lupishot 500 mg/500 mg Injection might induce adverse reactions impacting driving capabilities. Certain drug-related side effects, including hallucinations (visual, auditory, or sensory), can impair some individuals' ability to operate a vehicle.
KidneyCAUTION
For individuals with kidney impairment, administering Lupishot 500 mg/500 mg Injection requires careful consideration. Dosage modification of Lupishot 500 mg/500 mg Injection might be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Lupishot 500 mg/500 mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Lupishot 500mg/500mg Injection :
Should you forget a scheduled dose of Lupishot 500 mg/500 mg Injection, seek advice from your physician.
Facts to Know About Lupishot 500mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently